Clinical Trials Directory

Trials / Sponsors / Nykode Therapeutics ASA

Nykode Therapeutics ASA

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
WithdrawnEfficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Ca
HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer
Phase 22024-04-18
RecruitingSafety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
HPV Positive Oropharyngeal Squamous Cell Carcinoma, HNSCC
Phase 1 / Phase 22023-12-19
CompletedStudy of VB10.NEO in Combination With Atezolizumab in Solid Tumors
Solid Tumors, Adult
Phase 12021-12-21
CompletedA Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) an
COVID-19, Infection Viral, Infections
Phase 1 / Phase 22021-11-01
CompletedInvestigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer
Cervical Cancer, Cervix Cancer
Phase 22020-07-01
CompletedA Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immu
Locally Advanced or Metastatic Solid Tumours
Phase 1 / Phase 22018-04-04
CompletedAn Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
High Grade Cervical Intraepithelial Neoplasia
Phase 1 / Phase 22015-08-01